The Effect of Intravitral Injection of Triamcinolone Combined With Cataract Surgery (Phacoemulsification) on Diabetic Macular Edema and Diabetic Retinopathy
- Registration Number
- NCT00849537
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Brief Summary
In this study, regressed proliferative diabetic retinopathy, very severe, severe and moderate non-prolifrative diabetic retinopathy patients who were going to have a cataract surgery, underwent a complete eye examination, OCT, FAG and color photography 2 weeks prior to their operation. All patients divided in two: 1) control group (Phyco,PCIOL), 2) triamcinolone treatment group (Phaco with PCIOL+IVT). One month after surgery a complete eye examination will be done especially; IOP and endophthalmitis. A 6 month follow-up will be done for these two groups and diabetic retinopathy progression will be checked.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
- Diabetic patients with non-proliferative diabetic retinopathy and regressed PDR
Exclusion Criteria
- Uncontrolled HTN
- History of glaucoma
- Active PDR
- NVI
- TRD
- Any ophthalmic operation
- Renal problem(cr>3)
- CVA
- Uveitis
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Triamcinolone Triamcinolone Injection of intravitreal Triamcinolone
- Primary Outcome Measures
Name Time Method Macula diameter 6th week, 3, 6 months
- Secondary Outcome Measures
Name Time Method Diabetic retinopathy 6th weeks, 3 and 6 months later
Trial Locations
- Locations (2)
Ophthalmic Research Centre
🇮🇷Tehran, Iran, Islamic Republic of
Siamak Moradian,MD
🇮🇷Tehran, Iran, Islamic Republic of